Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
1.
Braz. j. med. biol. res ; 53(2): e8917, 2020. graf
Article Dans Anglais | LILACS | ID: biblio-1055492

Résumé

This study investigates the effect of the overexpression of the placental growth factor (PGF) and hyperoxia on lung development and determines whether anti-PGF antibody ameliorates hyperoxia-mediated impairment of lung development in newborn rats. After exposure to normoxic conditions for seven days, newborn rats subjected to normoxia were intraperitoneally or intratracheally injected with physiological saline, adenovirus-negative control (Ad-NC), or adenovirus-PGF (Ad-PGF) to create the Normoxia, Normoxia+Ad-NC, and Normoxia+Ad-PGF groups, respectively. Newborn rats subjected to hyperoxia were intraperitoneally injected with physiological saline or anti-PGF antibodies to create the Hyperoxia and Hyperoxia+anti-PGF groups, respectively. Our results revealed significant augmentation in the levels of PGF and its receptor Flt-1 in the lung tissues of newborn rats belonging to the Normoxia+Ad-PGF or Hyperoxia groups. PGF overexpression in these groups caused lung injury in newborn rats, while anti-PGF antibody treatment significantly cured the hyperoxia-induced lung injury. Moreover, PGF overexpression significantly increased TNF-α and Il-6 levels in the bronchoalveolar lavage (BAL) fluid of the Normoxia+Ad-PGF and Hyperoxia groups. However, their levels were significantly reduced in the BAL fluid of the Hyperoxia+anti-PGF group. Immunohistochemical analysis revealed that PGF overexpression and hyperoxia treatment significantly increased the expression of the angiogenesis marker, CD34. However, its expression was significantly decreased upon administration of anti-PGF antibodies (compared to the control group under hyperoxia). In conclusion, PGF overexpression impairs lung development in newborn rats while its inhibition using an anti-PGF antibody ameliorates the same. These results provided new insights for the clinical management of bronchopulmonary dysplasia in premature infants.


Sujets)
Animaux , Femelle , Grossesse , Rats , Autoanticorps/métabolisme , Hyperoxie/métabolisme , Lésion pulmonaire/métabolisme , Facteur de croissance placentaire/métabolisme , Anticorps monoclonaux/métabolisme , Autoanticorps/immunologie , Microscopie électronique à balayage , Hyperoxie/complications , Hyperoxie/imagerie diagnostique , Modèles animaux de maladie humaine , Lésion pulmonaire/anatomopathologie , Lésion pulmonaire/imagerie diagnostique , Facteur de croissance placentaire/immunologie , Animaux nouveau-nés , Anticorps monoclonaux/immunologie
2.
Clinics ; 68(5): 628-631, maio 2013. tab, graf
Article Dans Anglais | LILACS | ID: lil-675765

Résumé

OBJECTIVES: Familial steroid-sensitive idiopathic nephrotic syndrome is rare, and only approximately 3% of patients have affected siblings. METHODS: Herein, we report seven cases of patients with steroid-sensitive idiopathic nephrotic syndrome from three Chinese families. Mutational screening of the Nphs2 gene was performed in all the patients. RESULTS: All seven of the familial steroid-sensitive idiopathic nephrotic syndrome cases in our sample exhibited minimal change disease, and one case also presented with mesangial proliferative glomerulonephritis, according to the renal pathology. No significant was associations were found between Nphs2 gene mutations and the onset of proteinuria and nephrotic syndrome in these familial cases. CONCLUSIONS: The presence of minimal change disease is important, but it is not an unusual finding in patients with familial steroid-sensitive idiopathic nephrotic syndrome, which appears to be clinically benign and genetically distinct from other types of nephrosis. .


Sujets)
Adolescent , Adulte , Enfant , Enfant d'âge préscolaire , Femelle , Humains , Mâle , Protéines et peptides de signalisation intracellulaire/génétique , Protéines membranaires/génétique , Mutation/génétique , Syndrome néphrotique/génétique , Polymorphisme génétique/génétique , Maladies rares/génétique , Chine , Syndrome néphrotique/anatomopathologie , Pedigree , Maladies rares/anatomopathologie
SÉLECTION CITATIONS
Détails de la recherche